MedDataX Logo

Retrospective Analysis for the ClotTriever Catheter to Investigate Safety and Effectiveness in the Treatment of Acute and Subacute Iliofemoral Deep Vein Thrombosis (DVT)

NCT ID: NCT05740410

Last Updated: 2023-02-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-12

Study Completion Date

2022-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the safety and performance of the ClotTriever catheter in the treatment of patients with symptomatic iliofemoral deep vein thrombosis (DVT)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

NCT05701917

Venous Thromboembolism Deep Venous Thrombosis Post-Thrombotic Syndrome
RECRUITING NA

Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems

NCT06288906

Thrombosis, Venous
RECRUITING

Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation

NCT02066597

Deep Vein Thrombosis Venous Thromboembolism
TERMINATED PHASE2

Venous Thrombectomy/Thrombolysis Outcome Registry

NCT02113475

Deep Venous Thrombosis Post Thrombotic Syndrome
UNKNOWN

Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis

NCT00251771

Deep Vein Thrombosis
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data from patients in whom the ClotTriever catheter was used for treatment of iliofemoral DVT was retrospectively collected for up to 6 months after the procedure for evaluation of safety and effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Vein Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ClotTriever Catheter

Treatment of iliofemoral deep vein thrombosis with the ClotTriever catheter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* uni or bilateral iliofemoral DVT

Exclusion Criteria

* previously stented in treatment vein
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Klinikum Arnsberg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael H Lichtenberg, MD

Role: PRINCIPAL_INVESTIGATOR

Klinikum Hochsauerland GmbH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Hochsauerland GmbH

Arnsberg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ClotTriever

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis
NCT04411316 WITHDRAWN PHASE4
ClotTriever Outcomes (CLOUT) Registry
NCT03575364 COMPLETED
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
NCT05794165 ENROLLING_BY_INVITATION PHASE2
Second Line Endovascular Treatment in Acute DVT
NCT06486181 NOT_YET_RECRUITING PHASE4
Deep Venous Thrombosis and Long Term Complications
NCT05789108 RECRUITING NA
Treatment for Blood Clots in the Veins of the Legs
NCT00001713 COMPLETED PHASE1
Optimal Duration of Anticoagulation in Deep Venous Thrombosis
NCT01285661 COMPLETED PHASE3
Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome
NCT04597138 COMPLETED
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
NCT00451412 COMPLETED PHASE3
Treatment Patterns Among Patients With Venous Thromboembolism in the United States
NCT05795062 COMPLETED
AI-Based Prediction Model for Iliofemoral DVT Thrombolysis
NCT07181083 ACTIVE_NOT_RECRUITING
DUTCH CAVA-trial: CAtheter Versus Anticoagulation Alone for Acute Primary (Ilio)Femoral DVT.
NCT00970619 COMPLETED PHASE3
A Prospective Study to Assess the Risk Factors That Contribute to Thrombosis in Patients With Lower Limb Injuries.
NCT04608591 UNKNOWN
Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)
NCT00067093 COMPLETED PHASE3
Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis
NCT04670432 COMPLETED PHASE3
Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication
NCT01805544 COMPLETED
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
NCT02078154 TERMINATED
Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)
NCT01523418 WITHDRAWN
Risk Factors for Venous Thromboembolism in the Community
NCT00011180 COMPLETED
Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT
NCT04297787 COMPLETED NA
MDA D-Dimer / Recurrent DVT Study
NCT00157599 COMPLETED NA
Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
NCT04833764 UNKNOWN PHASE1/PHASE2
Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)
NCT03465735 TERMINATED NA
Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
NCT00082355 COMPLETED PHASE2
Understanding Risk Factors Involved in Developing a Second Blood Clot.
NCT00261014 UNKNOWN